Our AmplideX® Fragile X Dx and Carrier Screen Kit has been cleared by the United States Food and Drug Administration (FDA), making it the first and only test for the detection and quantification of expanded pathogenic repeat sequences to be cleared by the FDA.
Learn MoreThe AmplideX® PCR/CE SMN1/2 Plus Kit is a clinical research tool providing the most comprehensive analysis of SMN1 and SMN2 currently available from a commercial kit.
Learn moreThe AmplideX® PCR/CE HTT Kit is a simple, robust, and reliable test for the detection of CAG trinucleotide repeats within the HTT gene, aberrations which are associated with the development of Huntington’s Disease (HD).
Read moreAsuragen, Inc has developed an Armored RNA Quant® SARS-CoV-2 Control for use in developing assays in response to the COVID-19 pandemic.
Learn moreThe ACMG Annual Clinical Genetics Meeting provides genetics professionals with a high caliber scientific program that presents the latest developments and research in clinical genetics and genomics. Check back closer to the date of the show for more information regarding what we have planned! Learn more about about the conference: https://www.acmgmeeting.net/acmg2020/
